Halozyme Therapeutics, Inc. HALO
100.27 USD -0.40 (-0.40%)
At closeNov 13, 2026, 7:56 PM EST
99.48 -0.79 -0.79%
After hours · Nov 13, 7:56 PM ET
99.26 Day range 101.23
61.63 52-week range 131.18
- YTD
- +48.99%
- 1 year
- +40.85%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Annual income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 1.40B | 1.02B | 829.25M | 660.12M | 443.31M | |
| 1.40B | 1.02B | 829.25M | 660.12M | 443.31M | |
| 228.77M | 159.42M | 192.36M | 139.30M | 81.41M | |
| 1.17B | 855.91M | 636.89M | 520.81M | 361.90M | |
| 698.83M | 304.43M | 299.32M | 253.28M | 86.00M | |
| 366.38M | 79.05M | 76.36M | 66.61M | 35.67M | |
| 207.09M | 154.34M | 149.18M | 143.53M | 50.32M | |
| 469.01M | 551.48M | 337.57M | 267.53M | 275.90M | |
| 18.13M | 18.09M | 18.76M | 16.95M | 7.53M | |
| 149.99M | 113.04M | 66.73M | 46.79M | -154.19M | |
| 316.89M | 444.09M | 281.59M | 202.13M | 402.71M | |
| 316.89M | 444.09M | 281.59M | 202.13M | 402.71M | |
| 316.89M | 444.09M | 281.59M | 202.13M | 402.71M | |
| 316.89M | 444.09M | 281.59M | 202.13M | 402.71M | |
| 2.64 | 3.50 | 2.13 | 1.48 | 2.86 | |
| 2.64 | 3.50 | 2.13 | 1.48 | 2.86 | |
| 2.56 | 3.43 | 2.10 | 1.44 | 2.74 | |
| 485.00M | 575.23M | 367.09M | 265.87M | 256.04M | |
| 485.00M | 575.23M | 367.09M | 265.87M | 256.04M | |
| 119.84M | 126.83M | 131.93M | 136.84M | 140.65M | |
| 123.90M | 129.42M | 134.20M | 140.61M | 146.80M |
